This statement is not a human, veterinary, cosmetic, household, or personal-use preparation instruction
A 2023 paper in Pharmaceuticals (PMID: 37242459) documented anxiolytic, anticonvulsive, and antidepressant-like effects in animal behavioral assays and reported that BPC-157 attenuated benzodiazepine tolerance development and counteracted serotonin syndrome in rats
At 58 M and 580 M, cytotoxicity was not observed following 24 h treatment with all the samples
The label starts at 2.5 mg weekly, long-duration obesity evidence starts at 5 mg, and registered human activity has been measured as low as 1 mg in an early diabetes study. Each number answers a different question
Not a substitute for medical care.
Random-effects models for longitudinal data